Sergio Dompè, President of Farmindustria
Pharmaceuticals are paying for "the absence of a minister of industry and economic development". Sergio Dompé, president of Farmindustria, is convinced of this, according to which this is precisely one of the reasons why companies in the sector have been "penalized" in the financial manoeuvre.
Victims of a 'ghost' minister. Because, attacks Dompé in Milan, on the sidelines of a meeting on synergies between hospitals and industries organized by the Sacco hospital-university company, "if there had been a minister, he would have rebelled in all possible and imaginable ways" against the decision to leave also on the industry the cut in the margins of wholesalers, which originally should have fallen entirely on pharmacies with a discount of 3.65%.
The industry, according to the current text, will be required to pay 1.83%, ie 50% of the expected cut. Thus, continues Dompé, companies would receive less than the 60% of the retail price of a drug, "while a colleague of ours in England takes the 80%. A difference that has been widened even further to finance an increase in the margins of pharmacies".
The president of Farmindustria presses: "I cannot help but complain that this maneuver is sending a signal that depresses the investments of pharmaceutical companies. Neither their scientific nor economic value is recognized. And, at a time like this, I find that reducing the margins of companies is something that has the incredible.
I thought it was a joke, then I saw the measure materialize. And I can only express a dry and very negative comment".
Dompé is convinced that the lack of support from a minister of economic development was decisive, now that his role, following the resignation of Caludio Scajola, has been assumed ad interim by premier Silvio Berlusconi. "I remember that in France he emphasizes – the number one sponsor of the national pharmaceutical industry in the world is directly President Nicolas Sarkozy. I would like our government representatives to take an example from him". The "great fear" of the president of Farmindustria is that, "left completely without weapons to face the internal competitiveness that we also have in Europe with other countries that facilitate and push investments, we Italian pharmaceutical companies, instead of taking a step forward, are making three behind.I remember that in the last two years we have lost over 7,000 jobs, without anyone saying null
